Self-administration of misoprostol for termination of pregnancy: safety and efficacy

@article{Kiran2004SelfadministrationOM,
  title={Self-administration of misoprostol for termination of pregnancy: safety and efficacy},
  author={Usha Kiran and Pina Amin and Richard J A Penketh},
  journal={Journal of Obstetrics and Gynaecology},
  year={2004},
  volume={24},
  pages={155 - 156}
}
We conducted a retrospective study to determine the efficacy and safety of self-administration of vaginal misoprostol (following oral mifeprestone) for medical termination of pregnancy. This study revealed that self-administration was accepted by the majority of the patients (90%) and the success rate (98.4%) and duration of hospital stay was not altered significantly compared to our previous year's data, where women were administered vaginal misoprostol by the staff. Based on this study's… Expand
Self-administration of vaginal misoprostol after mifepristone for termination of pregnancy: Patient acceptability
  • U. Kiran, P. Amin, R. Penketh
  • Medicine
  • Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
  • 2006
TLDR
Although women were comfortable in self administering the pessaries in the hospital, they do not appear to be keen to do it at home without any supervision, however, as this is the first study in the UK involving women expressing their views regarding this issue, added research is required. Expand
Home self-administration of misoprostol for medical abortion up to 56 days' gestation
TLDR
This study suggests the feasibility and acceptability of home self-administration of misoprostol for medical abortion up to 56 days' gestation and these findings need to be assessed in the context of a randomised trial. Expand
Oral versus self‐administered vaginal misoprostol at home before surgical termination of pregnancy by Oppegaard et al.
  • C. Nzewi
  • Medicine
  • BJOG : an international journal of obstetrics and gynaecology
  • 2006
TLDR
The present study has shown the efficacy of self-administered vaginal misoprostol at home for cervical ripening in surgical TOP, and suggests that the demedicalise TOP should be aiming to demedICALise TOP, especially now that there are a variety of options for procuring it. Expand
Fertility control: Oral versus self‐administered vaginal misoprostol at home before surgical termination of pregnancy: a randomised controlled trial
Objective  To compare the impact of 400 μg oral versus self‐administered vaginal misoprostol at home on pre‐operative cervical priming in both primigravid and multigravid women prior to firstExpand
Female Reproductive Health
  • K. Piegsa
  • Medicine
  • Journal of Family Planning and Reproductive Health Care
  • 2005
TLDR
A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks’ gestation and a patient-centered, partially randomised prospective study. Expand
Yen and Jaffe's Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management
  • Faye Rodger
  • Medicine
  • Journal of Family Planning and Reproductive Health Care
  • 2005
TLDR
A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks’ gestation and a qualitative analysis of women’s experiences. Expand
Cervical dilation before first-trimester surgical abortion (<14 weeks' gestation). SFP Guideline 20071.
TLDR
Cervical priming increases preoperative cervical dilation, making the procedure easier and quicker for the physician, and insufficient data evaluating how cervical priming affects women's quality of life in relation to abortion. Expand
Clinical guidelines Cervical dilation before first-trimester surgical abortion (b14 weeks' gestation) ☆,☆☆,★,★★
TLDR
The Society of Family Planning recommends limiting consideration of cervical priming for women at increased risk of complications from cervical dilation, including those late in the first trimester, adolescents and women in whom cervical dilated is expected to be challenging. Expand
Women’s Stories of Abortion in Southern Gabon, Africa
  • Rosanna F. Hess
  • Medicine
  • Journal of transcultural nursing : official journal of the Transcultural Nursing Society
  • 2007
TLDR
The reasons women in rural, southern Gabon, Africa, chose to terminate their pregnancies, the methods used to induce abortions, and postabortion effects experienced by these women were explored to understand its affects on women’s reproductive health. Expand
Setting up an outpatient service for early medical termination
TLDR
The service is successful, viable for the future and has acceptably good patient outcomes, which are improving all the time. Expand
...
1
2
...

References

SHOWING 1-8 OF 8 REFERENCES
Misoprostol used alone for the termination of early pregnancy. A review of the evidence.
TLDR
Although the data are varied and difficult to compare, recent studies indicate that a misoprostol-alone regimen could be safe and effective as a method of medical abortion. Expand
Vaginal misoprostol administered at home after mifepristone (RU486) for abortion.
TLDR
Two days after taking mifepristone, misoprostol administered by vagina was found to be safe, highly effective, and acceptable to women and is a promising alternative to surgical abortion. Expand
Mifepristone-misoprostol medical abortion: home administration of misoprostol in Guadeloupe.
TLDR
It is suggested that home administration of misoprostol can be safe and effective in most nonindustrialized settings and may be possible to simplify the standard three clinic visit regimen. Expand
In-depth interviews with medical abortion clients: thoughts on the method and home administration of misoprostol.
TLDR
Home use of misoprostol affords women more flexibility, privacy, and control in their abortions, ultimately allowing them to seek their own comfort level. Expand
Mid‐trimester termination for fetal abnormality: advantages of a new regimen using mifepristone and misoprostol
TLDR
An open, exploratory study has assessed a new regimen which aims to refine the process of mid-trimester medical termination and may help to reduce the associated stress. Expand
Medical termination of pregnancy.
TLDR
A discussion supporting India's Medical Termination of Pregnancy Act of 1971 is presented and it is emphasized that the new legislation is not intended to encourage abortion as a method of birth control. Expand
Medical termination of pregnancy at 63 to 83 days gestation
TLDR
Assessment of the efficacy of a medical regimen for the termination of pregnancy within the gestational age range of 63 to 83 days finds it feasible to terminate pregnancy within this age range. Expand
Abortion Procedures. The Care of Women Requesting Induced abortion
  • 2003